Tech Company Financing Transactions
Xcovery Vision Funding Round
On 9/19/2012, Xcovery Vision received $6 million in Series B investment from private investors.
Transaction Overview
Company Name
Announced On
9/19/2012
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Proceeds Purpose
Xcovery Holdings, a biopharmaceutical start-up launched by Genzyme founder Sheridan Snyder, has raised more than $6 million in Series B funding to move two drug candidates further into clinical trials and develop other products in its pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
155 Gibbs St. 427
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Xcovery Vision is leading translational research efforts to develop novel treatments for eye disease by leveraging knowledge gained from Xcovery's oncology drug programs. Xcovery Vision has an exclusive license to develop Xcovery's novel kinase inhibitors for use in the field of ophthalmology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Richman
VP - Bus. Development
Daniel Salazar
Browse more venture capital transactions:
Prev: 9/19/2012: Selexys Pharmaceuticals venture capital transaction
Next: 9/19/2012: Perceptual Networks venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs